Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity
Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to assess the effects of chronic administration of Vyvanse
(lis-dexamphetamine) on glucose metabolism in a sample of children and adolescents with
Attention Deficit Hyperactivity Disorder (ADHD) who also have glucose intolerance and are
obese.